Genetron Health: Yun-Fu Hu
Chinese precision oncology company Genetron Holdings (Genetron Health) has appointed Yun-Fu Hu as chief medical officer. A former deputy director with the US Food and Drug Administration, Hu will be tasked to guide the company in its in vitro diagnostic device registration and regulatory affairs as well as its biopharma services business. At the FDA Hu led a team in premarket reviews and post-market compliance of IVD products and laboratory-developed tests for genetic testing, molecular cancer diagnostics, companion diagnostics, radiodosimetry, digital pathology, and artificial intelligence devices. Prior to joining FDA, Hu had more than 10 years of product development experience in the diagnostic and pharmaceutical industries.